MYO - Myomo, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD

Myomo, Inc.

One Broadway
14th Floor
Cambridge, MA 02142
United States
617-996-9058
http://www.myomo.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees49

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul R. GudonisChairman, Pres & CEO244.75kN/A1955
Mr. David A. HenryChief Financial Officer210.92kN/A1961
Mr. Jonathan NaftVP & GM200kN/A1965
Mr. Clifford J. ConneightonChief Marketing OfficerN/AN/A1950
Dr. Brandon Green DO, BOCPChief Medical OfficerN/AN/A1983
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.